Contributing to social implementation of cancer drug discovery seeds originating from academia
We are engaged in the drug development business in the field of oncology with sodium chlorite, which exerts anticancer effects based on a novel mechanism of action called the MA-T® system, and ALKBH inhibitors as a new target for epitranscriptomics drug discovery, and the drug discovery support business, which supports the creation of cell/animal models for research using tumor tissue derived from patients. We are also developing a drug discovery support business that supports the creation of cell/animal models for research using patient-derived tumor tissue.
In drug development, we will work in partnership with pharmaceutical companies (licensing out, co-discovery, etc.) to bring drugs to market as quickly as possible. In drug development, we will work to realize and launch drugs as quickly as possible through alliances with pharmaceutical companies (license-out, co-discovery, etc.). In the drug discovery support business, we will supply PDX/PDC that meet individual needs in the oncology field, and contribute to increasing development efficiency.
- MA-T® stands for Matching Transformation System®, an innovative oxidation control technology. By generating the required JAPAN MA-T INDUSTRIAL ASSOCIATION was established to promote and enhance the value of MA-T®, of which we are a member.